Aigerim Saulebayeva, MD
Ophthalmology · Hutchinson, MNNPI 1043744196
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,935 of the $7,773 with a category attached, or 63.5%. Genentech USA, Inc. accounts for 74.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $5,756 and has fallen 97.4% since, to $150 in 2025. Among ophthalmology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $168.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$6K
- Alcon$935
- AbbVie$334
- Apellis Pharmaceuticals, Inc.$164
- Aerie Pharmaceuticals, Inc.$124
- Johnson & Johnson Surgical Vision, Inc.$119
- plus $312 from 8 others
What the payments were for
- Consulting fees$4,93563%
- Travel & lodging$1953%
- Food & beverage$2,64434%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 9 | $5,786 |
| Alcon | 13 | $935 |
| AbbVie(2 entities) | 6 | $334 |
| Apellis Pharmaceuticals, Inc. | 3 | $164 |
| Aerie Pharmaceuticals, Inc. | 1 | $124 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $119 |
| Biogen | 4 | $94 |
| Amgen | 1 | $65 |
| Astellas Pharma US Inc | 2 | $52 |
| Eyepoint US, Inc. | 1 | $24 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Ocular Therapeutix, Inc. | 1 | $18 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$5,725
- Centurion$381
- Tecnis IOL$200
- ReSTOR$127
- Rhopressa$124
- Rocklatan$124
- AcrySof IQ VIVITY IOL$105
- OZURDEX$104
- Syfovre$103
How this compares
$7,773 in reported general payments places this provider in the 90th percentile of 330 ophthalmology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 138 | $6,268 |
| MoxifloxacinMoxifloxacin Hcl | 96 | $2,358 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 60 | $618 |
| Atropine Sulfate | 13 | $380 |
| Ketorolac Tromethamine | 19 | $281 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Hutchinson
- Edwin RyanMinneapolis$9.6M
- Mark LobanoffSt Louis Park$6.3M
- Richard LindstromBloomington$5.6M
- Thomas SamuelsonMinnetonka$435K
- Deborah RistvedtAlexandria$392K
- Yun-Sen ChuBloomington$222K
- Sophie BakriRochester$183K
- David HardtenMinneapolis$119K
- John ChenRochester$82K
- Christine LarsenBloomington$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.